Jack Cush - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jack Cush's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jack Cush
Verified
Executive Editor, RheumNow
Dallas
Beats
Social Equity , Global Development , Mental Health , Environment
Sophisticated mathematical theorems - I would be lost.
Content
By Jack Cush Verified| RheumNow Verified A single center, retrospective review patients undergoing knee joint fluid aspirations for presumed crystalline arthritis (CA) showed that synovial WBC may provide a useful diagnostic marker for SA with an optimal threshold of 50,000 cells/mm3. Distinguishing septic arthritis (SA) from crystalline arthritis (CA) or the coexistance of both can be diagnostically and clinically challenging.
By Jack Cush Verified| RheumNow Verified A prospective cohort study of seropositive arthralgia patients demonstrated that baseline characteristics and labs can be used to predict which arthralgia patients are at highest risk of developing rheumatoid arthritis (RA). These studies underscore the influence of anti-citrullinated protein antibodies (ACPA) and/or rheumatoid factor (IgM-RF).
By Jack Cush Verified| RheumNow Verified A single center, retrospective review patients undergoing knee joint fluid aspirations for presumed crystalline arthritis (CA) showed that synovial WBC may provide a useful diagnostic marker for SA with an optimal threshold of 50,000 cells/mm3. Distinguishing septic arthritis (SA) from crystalline arthritis (CA) or the coexistance of both can be diagnostically and clinically challenging.
Company Info
RheumNow
RheumNow is a news source and educational platform dedicated to rheumatology. It serves rheumatologists and those interested in the field by providing updates on the latest research, treatments, and clinical practices. The content is authored by experts, ensuring it is both authoritative and relevant. The platform offers a variety of services, including news articles on recent developments, insights into new treatments, and educational discussions on topics like biomarkers and disease management strategies. RheumNow also features expert interviews and sponsored content in collaboration with pharmaceutical companies, enhancing the educational resources available to healthcare professionals.
'+1 972-241-2939
Founded: 2014